Compound SMIP0004 has been found to restrain Skp2 expression, thus protecting p27 from degradation to induce p27 accumulation, finally inhibiting prostate cancer cell growth and inducing apoptosis60. This evidence concerns the gene SKP2 and prostate carcinoma.